QBREXZA (glycopyrronium tosylate)
TOPICAL ANTICHOLINERGIC HYPERHIDROSIS TREATMENT AGENTS · PRIMARY FOCAL HYPERHIDROSIS OF AXILLA
JOURNEY MEDICAL
Drug class
Topical Anticholinergic Hyperhidrosis Treatment Agents
Topical anticholinergic hyperhidrosis treatment agents are a pharmacologic class of locally applied muscarinic receptor antagonists. Read more about Topical Anticholinergic Hyperhidrosis Treatment Agents
3 drugs in this class 3 manufacturers
Drugs in Topical Anticholinergic Hyperhidrosis Treatment Agents
QBREXZA (glycopyrronium tosylate)
TOPICAL ANTICHOLINERGIC HYPERHIDROSIS TREATMENT AGENTS · PRIMARY FOCAL HYPERHIDROSIS OF AXILLA
DERMIRA/JOURNEY
SOFDRA (sofpironium bromide)
TOPICAL ANTICHOLINERGIC HYPERHIDROSIS TREATMENT AGENTS · PRIMARY FOCAL HYPERHIDROSIS OF AXILLA
BOTANIX SB INC.
Filter & compare in the drug finder →
Opens the drug finder with Topical Anticholinergic Hyperhidrosis Treatment Agents preselected. Add indication or manufacturer filters there.
Topical anticholinergic hyperhidrosis treatment agents are a pharmacologic class of locally applied muscarinic receptor antagonists.
While the FDA classifies specific members under the broader established pharmacologic class of anticholinergics, this specialized grouping represents topical formulations designed to manage excessive sweating.
These agents, which include glycopyrronium and sofpironium, work by competitively inhibiting muscarinic acetylcholine receptors on eccrine sweat glands to decrease localized sweat production while limiting the systemic adverse effects common with oral anticholinergics.
Their primary clinical indication is the management of primary axillary hyperhidrosis in adult and pediatric patients.
-
nih.gov
Topical anticholinergic hyperhidrosis treatment agents are a pharmacologic class of locally applied muscarinic receptor antagonists These agents, which include glycopyrronium and sofpironium, work by competitively inhibiting muscarinic acetylcholine receptors on eccrine sweat glands to decrease localized sweat production while limiting the systemic adverse effects common with oral anticholinergics
-
enavvi.com
Topical anticholinergic hyperhidrosis treatment agents are a pharmacologic class of locally applied muscarinic receptor antagonists These agents, which include glycopyrronium and sofpironium, work by competitively inhibiting muscarinic acetylcholine receptors on eccrine sweat glands to decrease localized sweat production while limiting the systemic adverse effects common with oral anticholinergics
-
fda.gov
While the FDA classifies specific members under the broader established pharmacologic class of anticholinergics, this specialized grouping represents topical formulations designed to manage excessive sweating
-
fda.gov
While the FDA classifies specific members under the broader established pharmacologic class of anticholinergics, this specialized grouping represents topical formulations designed to manage excessive sweating Their primary clinical indication is the management of primary axillary hyperhidrosis in adult and pediatric patients
-
hyperhidrosiscumc.com
These agents, which include glycopyrronium and sofpironium, work by competitively inhibiting muscarinic acetylcholine receptors on eccrine sweat glands to decrease localized sweat production while limiting the systemic adverse effects common with oral anticholinergics
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.